logo

Caribou Biosciences Inc (CRBU) Stock: Navigating Market Highs and Lows in 52 Weeks

OPEN Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Caribou Biosciences Inc’s current trading price is -82.67% away from its 52-week high, while its distance from the 52-week low is 5.25%. The stock’s price range during this period has varied between $0.95 and $5.77. The company, active in the Healthcare sector, saw a trading volume of around 0.59 million for the day, considerably lower average daily volume of 1.3 million observed over the last three months.

Caribou Biosciences Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $5.77 on 03/21/24, and the lowest price during the same period was recorded at $0.95 on 03/19/25.

How Financial Performance Impacts Market Capitalization

Caribou Biosciences Inc (CRBU) has experienced a quarterly decline of -47.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 93.00M and boasts a workforce of 147 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6766, with a change in price of -0.9201. Similarly, Caribou Biosciences Inc recorded 1,444,964 in trading volume during the last 100 days, posting a change of -47.92%.

How CRBU’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRBU stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.10.

CRBU Stock Stochastic Average

As of today, the raw stochastic average of Caribou Biosciences Inc over the past 50 days is 4.58%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 10.40%. Additionally, the Stochastic %K and %D values for the company were 3.55% and 3.76%, respectively, over the past 20 days.

CRBU Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -37.11%.However, over the last six months, we can see a stronger performance of -52.39%. Over the last 30 days, the price of CRBU has leaped by -30.08%. And in the last five days, it has surged by 1.46%.

Most Popular